No new digest content identified.
National Health Commission of the People’s Republic of China
Oct 24: Daily briefing on novel coronavirus cases in China
On Oct 23, 31 provincial-level regions and the Xinjiang Production and Construction Corps on the Chinese mainland reported 28 new cases of confirmed infections.
China joining COVAX for equitable global access to COVID-19 vaccines: FM spokesperson
BEIJING — China’s joining of COVAX is an important measure to uphold the concept of a shared community of health for all and fulfill its commitment on turning COVID-19 vaccines into a global public good, a foreign ministry spokesperson said on Oct 21.
“China is the largest economy supporting COVAX,” Zhao Lijian said at a daily press briefing, expressing the hope that China’s joining will motivate enterprises to increase their production capacity, ensure the output of vaccines, and promote the accessibility and affordability of vaccines in developing countries.
A total of 184 countries and economies have now joined COVAX, an international initiative aimed at ensuring equitable access to COVID-19 vaccines across the world, according to the World Health Organization Director-General Tedros Adhanom Ghebreyesus. China signed an agreement with Gavi, the Vaccine Alliance, officially joining COVAX on Oct. 8…
Trials of China’s vaccines make major progress
No severe adverse effects reported in 60,000 recipients, science official says
No recipient o f China’s COVID-19 vaccine approved for emergency use has reported severe adverse effects, and no vaccine recipient who went to work in countries where the pandemic is still ongoing has been infected, officials said on Oct 20.
China currently has 13 vaccine candidates in clinical trials, of which three inactivated vaccines and one adenovirus vector vaccine are in phase three trials overseas, said Tian Baoguo, deputy head of the Department of Science and Technology for Social Development of the Ministry of Science and Technology.
About 60,000 volunteers have been inoculated with the four vaccine candidates currently in phase three trials, Tian said at a news briefing held by the Joint Prevention and Control Mechanism of the State Council…